CLIAC Waiver Criteria Input Readied As FDA Gears Up To Draft Guidance

The Clinical Laboratory Improvement Advisory Committee is close to issuing waiver recommendations, after agreeing to largely adopt criteria developed by its CLIA waiver workgroup

More from Archive

More from Medtech Insight